Prediction of sites under adaptive evolution in flavin-containing monooxygenases: Selection pattern revisited

Chinese Science Bulletin

Volumn 56, Issue 12, 2011, Pages 1246-1255

  Hao, DaCheng ^a   Xiao, PeiGen ^b  

^a DALIAN JIAOTONG UNIVERSITY   (China)

^b INSTITUTE OF MEDICINAL PLANT DEVELOPMENT   (China)

Author keywords

adaptive evolution; evolutionary fingerprint; flavin containing monooxygenase; insertion domain; maximum likelihood; positive selection

Indexed keywords

ANURA; INVERTEBRATA; MAMMALIA; TAKIFUGU; TETRAODONTIDAE; VERTEBRATA;

EID: 79955156938     PISSN: 10016538     EISSN: 18619541     Source Type: Journal    
DOI: 10.1007/s11434-011-4380-8     Document Type: Article

References (44)

1. Krueger S K, Williams D E. Mammalian flavin-containing monooxygenases: Structure/function, genetic polymorphisms and role in drug metabolism. Pharmacol Ther, 2005, 106: 357-387.
2. Phillips I R, Shephard E A. Flavin-containing monooxygenases: Mutations, disease and drug response. Trends Pharmacol Sci, 2008, 29: 294-301.
3. Qiu H, Taudien S, Herlyn H, et al. CYP3 phylogenomics: Evidence for positive selection of CYP3A4 and CYP3A7. Pharmacogenet Genomics, 2008, 18: 53-66.
4. Zawaira A, Matimba A, Masimirembwa C. Prediction of sites under adaptive evolution in cytochrome P450 sequences and their relationship to substrate recognition sites. Pharmacogenet Genomics, 2008, 18: 467-476.
5. Chen X, Wang H, Zhou G, et al. Molecular population genetics of human CYP3A locus: Signatures of positive selection and implications for evolutionary environmental medicine. Environ Health Perspect, 2009, 117: 1541-1548.
6. Allerston C K, Shimizu M, Fujieda M, et al. Molecular evolution and balancing selection in the flavin-containing monooxygenase 3 gene (FMO 3). Pharmacogenet Genomics, 2007, 17: 827-839.
7. Hao D C, Chen S L, Xiao P G, et al. Molecular phylogeny, long-term evolution, and functional divergence of flavin-containing monooxygenases. Genetica, 2009, 137: 173-187.
8. Sea Urchin Genome Sequencing Consortium. The genome of the sea urchin Strongylocentrotus purpuratus. Science, 2006, 314: 941-952.
9. Eddy S R. Profile hidden Markov models. Bioinformatics, 1998, 14: 755-763.
10. Larkin M A, Blackshields G, Brown N P, et al. ClustalW and ClustalX version 2. Bioinformatics, 2007, 23: 2947-2948.
11. Birney E, Clamp M, Durbin R. GeneWise and Genomewise. Genome Res, 2004, 14: 988-995.
12. Burge C B, Karlin S. Finding the genes in genomic DNA. Curr Opin Struct Biol, 1998, 8: 346-354.
13. Wernersson R, Pedersen A G. RevTrans: Multiple alignment of coding DNA from aligned amino acid sequences. Nucleic Acids Res, 2003, 31: 3537-3539.
14. Saitou N, Nei M. The neighbor-joining method: A new method for reconstructing phylogenetic trees. Mol Biol Evol, 1987, 4: 406-425.
15. Tamura K, Dudley J, Nei M. MEGA4: Molecular evolutionary genetics analysis (MEGA) software version 4. 0. Mol Biol Evol, 2007, 24: 1596-1599.
16. Abascal F, Zardoya R, Posada D. ProtTest: Selection of best-fit models of protein evolution. Bioinformatics, 2005, 21: 2104-2105.
17. Ronquist F, Huelsenbeck J P. MrBayes 3: Bayesian phylogenetic inference under mixed models. Bioinformatics, 2003, 19: 1572-1574.
18. Zwickl D J. Genetic algorithm approaches for the phylogenetic analysis of large biological sequence datasets under the maximum likelihood criterion. Doctor dissertation. Austin: The University of Texas at Austin, 2006.
19. Eswaramoorthy S, Bonanno J B, Burley S K, et al. Mechanism of action of a flavin-containing monooxygenase. Proc Natl Acad Sci USA, 2006, 103: 9832-9837.
20. Zhang M, Robertus J D. Molecular cloning and characterization of a full-length flavin-dependent monooxygenase from yeast. Arch Biochem Biophys, 2002, 403: 277-283.
21. Yang Z, Nielsen R, Goldman N. Codon-substitution models for heterogeneous selection pressure at amino acid sites. Genetics, 2000, 155: 431-449.
22. Yang Z. PAML 4: A program package for phylogenetic analysis by maximum likelihood. Mol Biol Evol, 2007, 24: 1586-1591.
23. Doron-Faigenboim A, Pupko T A. Combined empirical and mechanistic codon model. Mol Biol Evol, 2007, 24: 388-397.
24. Kosakovsky P S L, Frost S D. Not so different after all: A comparison of methods for detecting amino acid sites under selection. Mol Biol Evol, 2005, 22: 1208-1222.
25. Kosakovsky P S L, Frost S D. Datamonkey: Rapid detection of selective pressure on individual sites of codon alignments. Bioinformatics, 2005, 21: 2531-2533.
26. Pond S L, Scheffler K, Gravenor M B, et al. Evolutionary fingerprinting of genes. Mol Biol Evol, 2010, 27: 520-536.
27. Zhang J. Parallel functional changes in the digestive RNases of ruminants and colobines by divergent amino acid substitutions. Mol Biol Evol, 2003, 20: 1310-1317.
28. Yang Z, Kumar S, Nei M. A new method of inference of ancestral nucleotide and amino acid sequences. Genetics, 1995, 141: 1641-1650.
29. Grantham R. Amino-acid difference formula to help explain protein evolution. Science, 1974, 185: 862-864.
30. Tang H, Wyckoff G J, Lu J, et al. A universal evolutionary index for amino acid changes. Mol Biol Evol, 2004, 21: 1548-1556.
31. Alfieri A, Malito E, Orru R, et al. Revealing the moonlighting role of NADP in the structure of a flavin-containing monooxygenase. Proc Natl Acad Sci USA, 2008, 105: 6572-6577.
32. Veeramah K R, Thomas M G, Weale M E. The potentially deleterious functional variant flavin-containing monooxygenase 2*1 is at high frequency throughout sub-Saharan Africa. Pharmacogenet Genomics, 2008, 18: 877-886.
33. Nei M, Rooney A P. Concerted and birth-and-death evolution of multigene families. Annu Rev Genet, 2005, 39: 121-152.
34. Hernandez D, Janmohamed A, Chandan P. Organization and evolution of the flavin-containing monooxygenase genes of human and mouse: Identification of novel gene and pseudogene clusters. Pharmacogenetics, 2004, 14: 117-130.
35. Li W H, Wu C I, Luo C C. Nonrandomness of point mutation as reflected in nucleotide substitutions in pseudogenes and its evolutionary implications. J Mol Evol, 1984, 21: 58-71.
36. Zhang J, Cashman J R. Quantitative analysis of FMO gene mRNA levels in human tissues. Drug Metab Dispos, 2006, 34: 19-26.
37. Overby L H, Buckpitt A R, Lawton M P. Characterization of flavin-containing monooxygenase 5 (FMO 5) cloned from human and guinea pig: Evidence that the unique catalytic properties of FMO 5 are not confined to the rabbit ortholog. Arch Biochem Biophys, 1995, 317: 275-284.
38. Cherrington N J, Cao Y, Cherrington J W. Physiological factors affecting protein expression of flavin-containing monooxygenases 1, 3 and 5. Xenobiotica, 1998, 28: 673-682.
39. Ohmi N, Yoshida H, Endo H. S-oxidation of S-methylesonarimod by flavin-containing monooxygenases in human liver microsomes. Xenobiotica, 2003, 33: 1221-1231.
40. Dihal A A, van der Woude H, Hendriksen P J, et al. Transcriptome and proteome profiling of colon mucosa from quercetin fed F344 rats point to tumor preventive mechanisms, increased mitochondrial fatty acid degradation and decreased glycolysis. Proteomics, 2008, 8: 45-61.
41. Lai W G, Farah N, Moniz G A, et al. A Baeyer-Villiger oxidation specifically catalyzed by human flavin-containing monooxygenase 5 (FMO 5). Drug Metab Dispos, 2011, 39: 61-70.
42. Nath N, Chattopadhyay M, Kodela R, et al. Modulation of stress genes expression profile by nitric oxide-releasing aspirin in Jurkat T leukemia cells. Biochem Pharmacol, 2010, 79: 1759-1771.
43. Lattard V, Zhang J, Tran Q, et al. Two new polymorphisms of the FMO 3 gene in Caucasian and African-American populations: Comparative genetic and functional studies. Drug Metab Dispos, 2003, 31: 854-860.
44. Orbás T, Zhang J, Cerny M A, et al. Investigation of structure and function of a catalytically efficient variant of the human flavin-containing monooxygenase form 3. Drug Metab Dispos, 2006, 34: 1995-2002.